A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,392,991 shares of BMY stock, worth $82 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,392,991
Previous 1,392,991 -0.0%
Holding current value
$82 Million
Previous $72.1 Million -0.0%
% of portfolio
0.22%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$39.66 - $51.75 $1.5 Million - $1.96 Million
-37,826 Reduced 2.64%
1,392,991 $72.1 Million
Q2 2024

Jul 29, 2024

BUY
$40.25 - $52.99 $21.3 Million - $28.1 Million
530,113 Added 58.86%
1,430,817 $59.4 Million
Q1 2024

Apr 25, 2024

SELL
$47.98 - $54.4 $544,812 - $617,712
-11,355 Reduced 1.24%
900,704 $48.8 Million
Q4 2023

Jan 30, 2024

SELL
$48.48 - $57.85 $11 Million - $13.1 Million
-226,406 Reduced 19.89%
912,059 $46.8 Million
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $3.93 Million - $4.4 Million
-67,943 Reduced 5.63%
1,138,465 $66.1 Million
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $777,962 - $863,806
12,211 Added 1.02%
1,206,408 $77.1 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $8.23 Million - $9.33 Million
125,204 Added 11.71%
1,194,197 $82.8 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $1.2 Million - $1.42 Million
17,557 Added 1.67%
1,068,993 $76.9 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $2,766 - $1.64 Million
21,281 Added 2.07%
1,051,436 $74.7 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $5.37 Million - $5.92 Million
-73,993 Reduced 6.7%
1,030,155 $79.3 Million
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $8.14 Million - $9.76 Million
132,341 Added 13.62%
1,104,148 $80.6 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $7.61 Million - $8.87 Million
-141,867 Reduced 12.74%
971,807 $60.6 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $2.18 Million - $2.55 Million
-36,796 Reduced 3.2%
1,113,674 $65.9 Million
Q2 2021

Jul 30, 2021

BUY
$61.91 - $67.42 $3.45 Million - $3.75 Million
55,675 Added 5.09%
1,150,470 $76.9 Million
Q1 2021

May 03, 2021

BUY
$59.34 - $66.74 $11.3 Million - $12.8 Million
191,148 Added 21.15%
1,094,795 $69.1 Million
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $913,446 - $1.04 Million
-15,820 Reduced 1.72%
903,647 $56.1 Million
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $7.05 Million - $7.82 Million
122,813 Added 15.42%
919,467 $55.4 Million
Q2 2020

Jul 28, 2020

SELL
$54.82 - $64.09 $11.1 Million - $13 Million
-202,531 Reduced 20.27%
796,654 $46.8 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $11.7 Million - $17.1 Million
252,961 Added 33.9%
999,185 $55.7 Million
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $17.9 Million - $23.3 Million
363,278 Added 94.86%
746,224 $47.9 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $171,208 - $202,992
-4,003 Reduced 1.03%
382,946 $19.4 Million
Q2 2019

Jul 30, 2019

SELL
$44.62 - $49.34 $6.6 Million - $7.3 Million
-147,852 Reduced 27.65%
386,949 $17.5 Million
Q1 2019

Apr 29, 2019

BUY
$45.12 - $53.8 $7.53 Million - $8.98 Million
166,852 Added 45.35%
534,801 $25.5 Million
Q4 2018

Jan 25, 2019

SELL
$48.76 - $63.23 $47,589 - $61,712
-976 Reduced 0.26%
367,949 $19.1 Million
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $296,425 - $334,344
-5,371 Reduced 1.43%
368,925 $22.9 Million
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $643,651 - $802,239
-12,738 Reduced 3.29%
374,296 $20.7 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $1.41 Million - $1.62 Million
23,470 Added 6.46%
387,034 $24.5 Million
Q4 2017

Jan 31, 2018

SELL
$59.94 - $65.35 $157,582 - $171,805
-2,629 Reduced 0.72%
363,564 $22.3 Million
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $20.2 Million - $23.3 Million
366,193
366,193 $23.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.